No profile data available.
Devonian Health Group Inc. (GSD.V) is a healthcare company in the digestive system treatment drugs industry, based in Québec, Canada, with about 8 full-time employees.
It reported revenue of 23.59 million CAD for fiscal year 2025, up 32.4% from fiscal year 2024, and net income of -6.01 million CAD. In Q2 2026 (the quarter ended January 31, 2026) revenue was 487,824 CAD, down 94.5% from a year before. Its market capitalization was 22.94 million CAD as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended July 31, 2025; market data as of October 9, 2026.
Devonian Health Group Inc. operates as a clinical stage biopharmaceutical corporation with novel therapeutic approaches targeting unmet medical needs in Canada and Internationally. It engages in the development of botanical drugs.
Devonian Health reported 23.59 million CAD in revenue for fiscal year 2025, up 32.4% from 17.82 million CAD in fiscal year 2024. In Q2 2026 revenue was 487,824 CAD.
22.94 million CAD as of October 9, 2026.